Fig. 1
From: Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer
Sampling process of PB samples from 74 BC patients. The 74 breast cancer patients were divided into NAT group (n = 13) and Adjuvant therapy group (n = 61) according to treatment methods. Peripheral blood of the patients was detected by flow cytometry before treatment or surgery. Abbreviations: AC, adriamycin combined with cyclophosphamide; EC, epirubicin combined with cyclophosphamide; T, docetaxel; P, paclitaxel; H, herceptin; PEC, paclitaxel combined with epirubicin and cyclophosphamide; TEC, docetaxel combined with epirubicin and cyclophosphamide